120 related articles for article (PubMed ID: 10561690)
1. Expression analysis of the PMP22 gene in glioma and osteogenic sarcoma cell lines.
Hühne K; Park O; Liehr T; Rautenstrauss B
J Neurosci Res; 1999 Dec; 58(5):624-31. PubMed ID: 10561690
[TBL] [Abstract][Full Text] [Related]
2. Characterization of PMP22 expression in osteosarcoma.
van Dartel M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Jul; 152(2):113-8. PubMed ID: 15262428
[TBL] [Abstract][Full Text] [Related]
3. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
4. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination.
Bosse F; Zoidl G; Wilms S; Gillen CP; Kuhn HG; Müller HW
J Neurosci Res; 1994 Mar; 37(4):529-37. PubMed ID: 8021974
[TBL] [Abstract][Full Text] [Related]
6. Overexpression through amplification of genes in chromosome region 17p11.2 approximately p12 in high-grade osteosarcoma.
van Dartel M; Redeker S; Bras J; Kool M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Jul; 152(1):8-14. PubMed ID: 15193436
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations in the Charcot-Marie-Tooth disease genes PMP22, MPZ, and GJB1.
Huehne K; Benes V; Thiel C; Kraus C; Kress W; Hoeltzenbein M; Ploner CJ; Kotzian J; Reis A; Rott HD; Rautenstrauss BW
Hum Mutat; 2003 Jan; 21(1):100. PubMed ID: 12497641
[TBL] [Abstract][Full Text] [Related]
8. Widespread expression of the peripheral myelin protein-22 gene (PMP22) in neural and non-neural tissues during murine development.
Baechner D; Liehr T; Hameister H; Altenberger H; Grehl H; Suter U; Rautenstrauss B
J Neurosci Res; 1995 Dec; 42(6):733-41. PubMed ID: 8847735
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis in Japanese patients with Charcot-Marie-Tooth disease: DGGE analysis for PMP22, MPZ, and Cx32/GJB1 mutations.
Numakura C; Lin C; Ikegami T; Guldberg P; Hayasaka K
Hum Mutat; 2002 Nov; 20(5):392-8. PubMed ID: 12402337
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of genes in 17p11.2 ~ p12 in osteosarcoma.
van Dartel M; Hulsebos TJ
Cancer Genet Cytogenet; 2004 Aug; 153(1):77-80. PubMed ID: 15325100
[TBL] [Abstract][Full Text] [Related]
11. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
12. Identification of the regulatory region of the peripheral myelin protein 22 (PMP22) gene that directs temporal and spatial expression in development and regeneration of peripheral nerves.
Maier M; Berger P; Nave KA; Suter U
Mol Cell Neurosci; 2002 May; 20(1):93-109. PubMed ID: 12056842
[TBL] [Abstract][Full Text] [Related]
13. Distinct disease mechanisms in peripheral neuropathies due to altered peripheral myelin protein 22 gene dosage or a Pmp22 point mutation.
Giambonini-Brugnoli G; Buchstaller J; Sommer L; Suter U; Mantei N
Neurobiol Dis; 2005 Apr; 18(3):656-68. PubMed ID: 15755691
[TBL] [Abstract][Full Text] [Related]
14. Charcot-Marie-Tooth disease type 1A: molecular mechanisms of gene dosage and point mutation underlying a common inherited peripheral neuropathy.
Roa BB; Garcia CA; Lupski JR
Int J Neurol; 1991-1992; 25-26():97-107. PubMed ID: 11980069
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the peripheral myelin protein 22kDa (PMP22) in neural and non-neural tissue types of adult wildtype and Trembler mice--a comparative study.
Rautenstrauss B; Zechner U; Hameister H; Grehl H; Liehr T
J Peripher Nerv Syst; 1998; 3(2):117-24. PubMed ID: 10959245
[TBL] [Abstract][Full Text] [Related]
16. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients.
Mersiyanova IV; Ismailov SM; Polyakov AV; Dadali EL; Fedotov VP; Nelis E; Löfgren A; Timmerman V; van Broeckhoven C; Evgrafov OV
Hum Mutat; 2000; 15(4):340-7. PubMed ID: 10737979
[TBL] [Abstract][Full Text] [Related]
17. Peripheral myelin protein 22 is expressed in human central nervous system.
Ohsawa Y; Murakami T; Miyazaki Y; Shirabe T; Sunada Y
J Neurol Sci; 2006 Aug; 247(1):11-5. PubMed ID: 16626749
[TBL] [Abstract][Full Text] [Related]
18. Expression of T-type calcium channel splice variants in human glioma.
Latour I; Louw DF; Beedle AM; Hamid J; Sutherland GR; Zamponi GW
Glia; 2004 Nov; 48(2):112-9. PubMed ID: 15378657
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional startpoints and methylation patterns in the PMP22 promoters of peripheral nerve, leukocytes and tumor cell lines.
Huehne K; Rautenstrauss B
Int J Mol Med; 2001 Jun; 7(6):669-75. PubMed ID: 11351283
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
